title: DIABETES AND PREDIABETES ARE SIGNIFICANTLY HIGHER IN MORBIDLY OBESE CHILDREN COMPARED WITH OBESE CHILDREN.
abstract: OBJECTIVE
  The objective of this study was to examine the prevalence and characteristics of comorbidities in obese and morbidly obese children with a comparison between the 2 sets of children.
  
  
  METHODS
  This was a retrospective electronic chart review of obese and morbidly obese children and adolescents as defined by body mass index. We evaluated medical history of comorbid conditions, medication use, and cardiovascular risk markers, including blood pressure, lipid profile, and glycosylated hemoglobin.
  
  
  RESULTS
  There were 1,111 subjects (African American = 635; non-Hispanic white = 364; Hispanic = 36; others = 86), of which 274 were obese and 837 were morbidly obese children with a mean age of 12.7 ± 3.37 years. Morbidly obese children had a higher prevalence of prediabetes (19.5% of obese versus 27.3% of morbidly obese; P<.0001) and type 2 diabetes (39.8% of obese versus 52.4% of morbidly obese; P<.0001). Use of medications for treatment of asthma was significantly higher in the morbidly obese group compared with the obese group (21% versus 14%; P = .01).
  
  
  CONCLUSIONS
  Morbidly obese children have a higher prevalence of diabetes, prediabetes, and use of asthma medications compared with obese children.
authors.forename: Matthew
authors.initials: M
authors.lastname: Propst
authors.forename: Caroline
authors.initials: C
authors.lastname: Colvin
authors.forename: Russell L
authors.initials: RL
authors.lastname: Griffin
authors.forename: Bhuvana
authors.initials: B
authors.lastname: Sunil
authors.forename: Carroll M
authors.initials: CM
authors.lastname: Harmon
authors.forename: Govardhana
authors.initials: G
authors.lastname: Yannam
authors.forename: Joffre E
authors.initials: JE
authors.lastname: Johnson
authors.forename: Cody Brian
authors.initials: CB
authors.lastname: Smith
authors.forename: Alan P
authors.initials: AP
authors.lastname: Lucas
authors.forename: Benjamin Tuanama
authors.initials: BT
authors.lastname: Diaz
authors.forename: Ambika P
authors.initials: AP
authors.lastname: Ashraf
mesh_terms: D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage; D001794:Blood Pressure; D015992:Body Mass Index; D002318:Cardiovascular Diseases; D002648:Child; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D005006:Ethnicity; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008055:Lipids / Q000097:blood; D008297:Male; D009765:Obesity / Q000150:complications*; D009767:Obesity, Morbid / Q000150:complications*; D011236:Prediabetic State / Q000453:epidemiology*; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D018927:Anti-Asthmatic Agents; D006442:Glycated Hemoglobin; D008055:Lipids